Skip to main content
. 2016 May 14;20(9):1045–1054. doi: 10.1080/14728222.2016.1180368

Figure 3.

Figure 3.

Image of progesterone receptor (PR) immuno-reactivity in human endometrium after administration of a selective PR modulator (SPRM). Note intense positive (brown) immunostaining in the glandular epithelium (g) and virtual absence of immuno-reactivity in the stroma (s). Image kindly provided by Professor Alistair Williams, University of Edinburgh. Full color available online.